Skip to main content

BARCLAYS PLC

Position in GRAL — GRAIL, Inc.

CIK 312069 LONDON, X0

Position in GRAL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,168,809
-$7,586,258 QoQ
Shares Held
61,316
-51.2% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Jun 30, 2024
CallValue
$902,526
CallShares
58,720
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $2,117,156,031 across 34 Diagnostics & Research names. GRAL ranks #18 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GRAL

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,168,809 61,316
2025-12-31 $10,755,067 125,658
2025-09-30 $5,558,574 94,006
2025-06-30 $5,569,453 108,313
2025-03-31 $689,553 26,999
2024-12-31 $430,309 24,107
2024-09-30 $267,989 19,476
2024-06-30 $902,526 58,720
2024-06-30 $505,841 32,911